A detailed history of Vigilare Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Vigilare Wealth Management holds 2,649 shares of LLY stock, worth $2.11 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
2,649
Previous 2,804 5.53%
Holding current value
$2.11 Million
Previous $2.54 Million 7.57%
% of portfolio
0.97%
Previous 1.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$772.14 - $960.02 $119,681 - $148,803
-155 Reduced 5.53%
2,649 $2.35 Million
Q2 2024

Jul 15, 2024

SELL
$724.87 - $909.04 $33,344 - $41,815
-46 Reduced 1.61%
2,804 $2.54 Million
Q1 2024

Apr 26, 2024

SELL
$592.2 - $792.28 $259,975 - $347,810
-439 Reduced 13.35%
2,850 $2.22 Million
Q4 2023

Jan 08, 2024

BUY
$525.19 - $619.13 $525 - $619
1 Added 0.03%
3,289 $1.92 Million
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $13,041 - $17,979
30 Added 0.92%
3,288 $1.77 Million
Q2 2023

Jul 11, 2023

BUY
$350.74 - $468.98 $350 - $468
1 Added 0.03%
3,258 $1.53 Million
Q1 2023

Apr 17, 2023

SELL
$310.63 - $364.82 $128,911 - $151,400
-415 Reduced 11.3%
3,257 $1.12 Million
Q4 2022

Jan 10, 2023

BUY
$321.55 - $374.67 $63,023 - $73,435
196 Added 5.64%
3,672 $0
Q3 2022

Oct 20, 2022

BUY
$296.48 - $337.87 $77,381 - $88,184
261 Added 8.12%
3,476 $1.12 Million
Q1 2022

Apr 06, 2022

BUY
$234.69 - $291.66 $97,631 - $121,330
416 Added 14.86%
3,215 $921,000
Q4 2021

Jan 07, 2022

BUY
$224.85 - $279.04 $10,118 - $12,556
45 Added 1.63%
2,799 $773,000
Q3 2021

Oct 19, 2021

SELL
$221.6 - $272.71 $156,892 - $193,078
-708 Reduced 20.45%
2,754 $636,000
Q2 2021

Jul 16, 2021

SELL
$180.55 - $233.54 $112,121 - $145,028
-621 Reduced 15.21%
3,462 $795,000
Q1 2021

Apr 29, 2021

BUY
$164.32 - $212.72 $670,918 - $868,535
4,083 New
4,083 $763,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vigilare Wealth Management Portfolio

Follow Vigilare Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Vigilare Wealth Management with notifications on news.